Top Markets
Coin of the day
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Clasificación en acciones #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Precio por acción
$0.05207079
Última sincronización: 2023-11-15
Capitalización bursátil
$3.38M
Cambio (1 día)
0.13%
Cambio (1 año)
0.00%
País
AU
Comercio Kazia Therapeutics Limited (KZA)

Categoría

Historial del precio de la acción de Kazia Therapeutics Limited (KZA)
Precio más alto de cierre: $0.05 el 2023-11-01

Precio más bajo de cierre: $2.34 el 1994-09-01
Historial del precio de la acción de Kazia Therapeutics Limited desde 1994 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 -14.41%
2022 -93.21%
2021 -12.26%
2020 134.56%
2019 60.49%
2018 -10.55%
2017 -54.36%
2016 -26.11%
2015 4.87%
2014 -53.60%
2013 40.89%
2012 29.78%
2011 -12.03%
2010 -76.36%
2009 -1.22%
2008 -56.70%
2007 -44.36%
2006 -47.25%
2005 -15.26%
2004 -19.24%
2003 269.42%
2002 32.67%
2001 -37.00%
2000 -7.16%
1999 14.60%
1998 11.28%
1997 0.36%
1996 133.15%
1995 54.37%
1994 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE